Recommended Clinical Care Pathway with FIB-4 underestimates the prevalence of Advanced Fibrosis, compared to sequential CCP with LIVERSTAT and LSM (NHANES)
Fasting vs non-fasting: assessment of the impact on LIVERSTAT
LIVERFASt-LFS NIT for Fatty Liver Disease, for Primary Care Provider (PCP) screening
Assessment of Fatty Liver Disease using LIVERFASt in South-East Asia (real-world evidence)
Comparative Performances of LIVERFASt, Fibroscan and other NITs for severe fibrosis in NAFLD patients (Bordeaux cohort)
Simulating clinical confidence intervals for black-box algorithmic predictions of liver steatosis
Comparison analysis of FIB-4, LIVERFASt, LSM in Sequential and Combinatory Pathways for NAFLD
Noninvasive LIVERFASt transition rate to liver fibrosis, similar to liver biopsy in NAFLD patients
Repeated noninvasive liver biopsy surrogate LIVERFASt correlates with BMI and liver enzyme improvements
Comparative Assessment of NIMs (LIVERFASt/ELF/FIB-4/LSM) in a prospective cohort with chronic liver diseases (Thailand)
